Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-20
1995-12-26
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548181, 548183, C07D27734, A61K 31425
Patent
active
054788536
ABSTRACT:
The compounds are 5-(4-substituted benzyl)thiazolidine-2,4-diones, enantiomers, diastereoisomers and pharmaceutically tolerable salts thereof, useful for treating conditions of insulin-resistance and/or non insulin-dependent diabetes.
A compound disclosed is: 5-{4-[2-(2-methoxy-5-chlorobenzamido)ethyl]benzyl}thiazolidine-2,4-dione.
REFERENCES:
patent: 5120754 (1992-06-01), Clark
Sohda, Chem Pharm Bull 30 3580 (1982).
Charton Yves
Duhault Jacques
Espinal Joseph
Regnier Gilbert
Adir et Compagnie
Gerstl Robert
Hueschen Gordon W.
LandOfFree
Thazolidinedione compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thazolidinedione compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thazolidinedione compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1369542